| 000 | 01759 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515011259.0 | ||
| 264 | 0 | _c20060131 | |
| 008 | 200601s 0 0 eng d | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuklińska, A M | |
| 245 | 0 | 0 |
_aLow dose rofecoxib, inflammation and prostacyclin synthesis in acute coronary syndromes. _h[electronic resource] |
| 260 |
_bRoczniki Akademii Medycznej w Bialymstoku (1995) _c2005 |
||
| 300 |
_a339-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xblood |
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aC-Reactive Protein _xmetabolism |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEpoprostenol _xbiosynthesis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aLactones _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSimvastatin _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfones _xadministration & dosage |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _aMusiał, W J | |
| 700 | 1 | _aKamiński, K A | |
| 700 | 1 | _aKralisz, P | |
| 700 | 1 | _aModrzejewski, W | |
| 700 | 1 | _aSobkowicz, B | |
| 700 | 1 | _aDobrzycki, S | |
| 700 | 1 | _aStec, S | |
| 700 | 1 | _aWojtkowska, I | |
| 773 | 0 |
_tRoczniki Akademii Medycznej w Bialymstoku (1995) _gvol. 50 _gp. 339-42 |
|
| 999 |
_c15979117 _d15979117 |
||